The Terry F. Davies Distinguished Professorship Series, hosted by the Institute for Translational Medicine and Pharmacology at the Icahn School of Medicine at Mount Sinai, is proud to welcome E. Dale Abel, MBBS, DPhil, for a lecture on "Cardiometabolic Disease: A Mitochondrial Perspective." Dr. Abel is the William S. Adams Distinguished Professor of Medicine and Chair of the Department of Medicine at the David Geffen School of Medicine, UCLA, and Executive Medical Director of UCLA Health. He graduated with distinction from the University of the West Indies School of Medicine, earned his DPhil from Oxford University as a Rhodes Scholar, and completed training in internal medicine at Northwestern University and in endocrinology at Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Abel has made seminal contributions to understanding the role of altered mitochondrial metabolism in the pathophysiology of diabetic cardiomyopathy, and his laboratory has elucidated critical roles for insulin and IGF1 signaling in cardiac health and disease. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, and is past President of both the Endocrine Society and the Association of Professors of Medicine. 

The Terry F. Davies Distinguished Professorship Series is held annually in honor of Dr. Terry F. Davies' long and distinguished record of significant contributions to our knowledge of endocrine physiology and pathology. Dr. Davies is the Florence and Theodore Baumritter Professor of Medicine at the Icahn School of Medicine at Mount Sinai, where he has spent most of his career advancing research in autoimmune thyroid disease and endocrine physiology. Initiated in 2023, this lecture series reflects the Institute's commitment to honoring Dr. Davies' legacy by bringing the world's foremost biomedical scientists to Mount Sinai to share their discoveries and inspire the next generation of researchers and clinicians.